What Is a Prostate Ultrasound and What Should I Expect?

A prostate ultrasound is an imaging exam that uses sound waves to create a picture of the prostate gland, most often by inserting a small probe into the rectum. It takes roughly 10 to 20 minutes when done for imaging alone, though the appointment runs longer if tissue samples (biopsies) are taken at the same time. The procedure is one of the most common steps in evaluating prostate problems, from an enlarged gland causing urinary symptoms to a suspicion of cancer after a blood test comes back elevated. What you actually experience depends heavily on whether you are having a simple imaging study or an ultrasound-guided biopsy, and the distinction matters more than most patient handouts let on.

Why Doctors Order a Prostate Ultrasound

The most frequent reason is an elevated prostate-specific antigen (PSA) level, an abnormal digital rectal exam, or both. When PSA levels cross a certain threshold, further evaluation with ultrasound-guided biopsy is standard practice to check for cancer.¹ But cancer screening is not the only use. Prostate ultrasound also helps measure the gland’s size before surgery for benign enlargement, guides placement of radiation seeds during brachytherapy, evaluates chronic pelvic pain, and monitors treatment response over time.

If your doctor orders the exam purely to measure prostate volume or check the gland’s shape, the experience is brief and relatively comfortable. When the purpose is biopsy, the procedure involves a needle and additional preparation, which changes the experience considerably.

Transrectal Versus Transabdominal Approaches

There are two main ways to image the prostate with ultrasound. The transrectal approach (TRUS) places a narrow ultrasound probe directly into the rectum, putting it just millimeters from the prostate. This proximity produces sharper, higher-resolution images and has been the default technique since the 1970s.² The transabdominal approach (TAUS) scans through the lower belly wall, much like an abdominal ultrasound you may have seen during pregnancy care. It is completely external and painless but provides a less detailed view.

For smaller prostates, the two methods produce volume measurements that are effectively interchangeable. A study comparing the approaches found that for glands under about 30 cubic centimeters, transabdominal and transrectal estimates agreed well. For larger prostates, however, the researchers recommended transrectal ultrasound or cross-sectional imaging like MRI for accuracy.³ A separate prospective study confirmed that transabdominal ultrasound slightly underestimates volume compared to MRI, though it actually overestimated cancer risk less frequently than the transrectal method.⁴

In practice, most biopsy procedures use the transrectal route because the probe can guide a needle directly into the gland. If your doctor only needs a rough size measurement to plan medication, a transabdominal scan might be all you get.

What Happens During a Transrectal Ultrasound

You will typically lie on your left side with your knees drawn toward your chest. The ultrasound probe is about the width of a finger, coated in lubricant and covered with a thin sheath. The clinician gently inserts it into the rectum and angles it forward to visualize the prostate on a screen. You will feel pressure and fullness, similar to the sensation of a digital rectal exam but lasting longer. Most people describe it as uncomfortable rather than painful.

The sonographer or urologist will measure the prostate in three dimensions and use those measurements to estimate volume. The standard approach treats the prostate as roughly egg-shaped and multiplies its length, height, and width by a coefficient. Research on fresh surgical specimens has found that the commonly used coefficient tends to overestimate volume slightly, and that a refined coefficient of about 0.66 produces more accurate results.⁵ Newer formulas that account for the prostate’s actual shape, rather than assuming a perfect ellipse, have shown even better accuracy in identifying patients who need further testing.⁶

If imaging is the only goal, the probe comes out after a few minutes of scanning, and you are done. There is usually no special preparation beyond possibly emptying your bladder, and you can drive yourself home immediately.

When a Biopsy Is Part of the Procedure

If the purpose is tissue sampling, the experience is more involved. An ultrasound-guided prostate biopsy uses the same transrectal probe, but a needle guide is attached so that small tissue cores can be taken from specific areas of the gland. A spring-loaded biopsy gun fires a thin needle through the rectal wall into the prostate, and the ultrasound image shows exactly where each sample comes from. In a typical systematic biopsy, cores are taken from multiple zones on both sides of the gland.⁷

Before the cores are taken, a local anesthetic is injected around the nerve bundles near the base of the prostate. This is sometimes called a periprostatic nerve block and significantly dulls the sensation. You will still hear a clicking sound from the biopsy gun and feel a quick pinch or sting with each core, but most men tolerate it well. The entire biopsy portion typically adds 10 to 15 minutes to the visit.

Preparing for a Biopsy

Your doctor’s office will give you specific instructions, which usually include antibiotic pills to take before the procedure and sometimes a rectal enema the night before. A randomized trial comparing a simple rectal enema with a full bowel preparation found that the enema was less burdensome and equally effective at reducing discomfort.⁸ You may also be told to stop blood-thinning medications for a few days beforehand, though this varies by practice and your individual risk.

Common Side Effects After Biopsy

Blood in the urine, stool, and semen is the most common aftereffect and usually resolves on its own. The most persistent of these is blood in the semen: a prospective study found that roughly nine out of ten men who could ejaculate experienced it, with an average duration of about four weeks.⁹ This is harmless but understandably alarming if nobody warns you. Blood in the urine usually clears within a few days, and rectal spotting tends to stop even sooner.

Mild soreness or a dull ache in the rectal area for a day or two is also normal. Most men return to their usual activities the next day, though strenuous exercise and sexual activity are often discouraged for 48 to 72 hours.

Infection Risk and How It Is Managed

Because the transrectal route passes a needle through the rectal wall, bacteria from the gut can enter the prostate and bloodstream. This is why prophylactic antibiotics are standard. Historically, fluoroquinolones like ciprofloxacin were the go-to choice, but rising rates of antibiotic-resistant bacteria in the gut have complicated the picture. Research has found that roughly four in ten men undergoing prostate biopsy carry fluoroquinolone-resistant bacteria in their rectal flora.¹⁰

When standard antibiotics do not match the bacteria actually present, the risk of post-biopsy infection rises sharply. A multicenter randomized trial showed that men given ciprofloxacin who happened to carry resistant bacteria had a roughly six-fold higher infection rate than those whose bacteria were sensitive to the drug. When prophylaxis was tailored based on a rectal swab taken before the procedure, infection rates dropped to similarly low levels regardless of resistance status.¹¹ Not all practices perform rectal swabs routinely, so it is worth asking your urologist how they choose your antibiotics.

Additional risk factors for post-biopsy infection include higher body mass, diabetes, and having a urinary catheter in place beforehand. In one large analysis, these three factors stood out independently.¹² Fever above about 38°C (101°F), chills, or difficulty urinating in the days after biopsy warrants an urgent call to your doctor. Serious infection requiring hospitalization is uncommon but real.

The Transperineal Alternative

A growing number of centers now offer transperineal biopsy, which passes the needle through the skin between the scrotum and the anus rather than through the rectal wall. Because the needle never enters the rectum, the risk of gut bacteria causing infection drops dramatically. A randomized trial (the PREVENT trial) reported zero infections in the transperineal group compared to about 1.6% in the transrectal group.¹³ Cancer detection rates were essentially the same between the two approaches, confirmed by a meta-analysis of eleven trials that found no significant difference.¹⁴

The trade-off is that transperineal biopsy can be slightly more uncomfortable in the perineal area afterward, and some centers perform it under sedation or general anesthesia rather than just local numbing. If you are concerned about infection risk, especially if you have diabetes or are immunocompromised, ask whether transperineal biopsy is available.

MRI-Ultrasound Fusion Biopsy

Standard ultrasound-guided biopsy is somewhat blind: the clinician samples tissue from pre-set zones of the prostate rather than from a specific suspicious spot, because conventional grayscale ultrasound has limited ability to distinguish cancerous from benign tissue.² MRI-ultrasound fusion changes this by overlaying a previously obtained MRI scan onto the real-time ultrasound image, letting the doctor steer the needle directly into suspicious areas identified on MRI.

The clinical advantage is substantial. A systematic review and meta-analysis found that MRI-guided biopsy detected clinically significant prostate cancer at a significantly higher rate than standard ultrasound-guided biopsy, with a pooled detection rate of 83% versus 63%.¹⁵ Work with early fusion devices found that targeted biopsies were two to three times more sensitive for detecting cancer than untargeted systematic sampling, and that nearly 40% of men with higher-grade disease were diagnosed only because of the targeted cores.¹⁶

In day-to-day practice, many centers now combine both techniques: they take targeted cores from MRI-suspicious areas and systematic cores from the rest of the gland. A study of over 500 patients found that fusion biopsy alone caught about 43% of cancers while systematic biopsy alone caught about 39%, but combining both improved the overall detection rate and caught more clinically significant tumors than either method on its own.¹⁷ From your perspective as a patient, the experience during fusion biopsy feels the same as a standard biopsy. The extra step is the MRI done days or weeks beforehand.

Managing Pain and Anxiety

Pre-procedure anxiety is extremely common and is worth taking seriously because it can heighten your perception of pain during the exam. A narrative review of anxiety management strategies noted that higher anxiety levels before biopsy are linked to more pain, longer procedure times, and lower satisfaction.¹⁸

Several approaches have been tested. A randomized trial found that simple conversation with a nurse during the biopsy significantly reduced both pain and anxiety scores compared to a silent procedure.¹⁹ Virtual reality headsets showing calming environments have also shown strong reductions in anxiety and increases in comfort during the procedure.²⁰ If your facility does not offer these, even knowing what the sounds and sensations will be ahead of time can help. Ask your urologist to walk you through each step so nothing catches you off guard.

Newer Ultrasound Technologies

Conventional grayscale ultrasound shows the prostate’s anatomy but struggles to tell cancerous tissue from normal tissue. Researchers have been developing multiparametric ultrasound, which combines the standard grayscale image with additional techniques like shear wave elastography (which measures tissue stiffness) and contrast-enhanced ultrasound (which tracks blood flow patterns). In a study comparing these tools against surgical specimens, multiparametric ultrasound detected clinically significant cancer with a sensitivity of about 74%, meaningfully better than any of the individual techniques used alone, each of which hovered around 55% to 59%.²¹

Micro-ultrasound is another emerging option. It operates at a much higher frequency than standard transrectal probes, producing images detailed enough to identify suspicious areas in real time during biopsy, potentially reducing the need for a separate MRI. A systematic review and meta-analysis of fifteen studies found that micro-ultrasound–targeted biopsy detected clinically significant cancer at a rate statistically indistinguishable from MRI-targeted biopsy.²² This is noteworthy because MRI is expensive, requires specialized radiologists, and is not available everywhere. If micro-ultrasound delivers comparable accuracy in a single clinic visit, it could make targeted biopsy more accessible globally.

When Readings Disagree

If your prostate ultrasound is paired with an MRI for fusion biopsy, be aware that MRI interpretation can vary between radiologists. A study comparing initial MRI reads with second-opinion reads by a specialist uroradiologist found agreement only about 58% of the time. The specialist reads were significantly better at identifying clinically significant cancers, detecting them at nearly double the rate of the initial readings.²³ This does not mean your initial MRI was done poorly; prostate MRI is genuinely difficult to interpret consistently. If your MRI report is ambiguous or borderline, seeking a second read from a center with high prostate MRI volume is a reasonable step.

Ultrasound images themselves are less prone to this particular problem because the clinical decisions based on them are less about reading subtle tissue signals and more about guiding the biopsy needle to the right location. The image quality does depend on the sonographer’s technique and equipment, but the stakes of an individual image reading are lower when the biopsy cores go to a pathologist for a definitive answer under a microscope.

Who Should Think Twice

Prostate ultrasound on its own carries minimal risk. But ultrasound-guided biopsy, particularly via the transrectal route, deserves a genuine risk-benefit conversation in certain situations. Men on blood thinners face higher bleeding risk, and managing anticoagulation around the biopsy date requires coordination with your prescribing doctor. Those with active rectal conditions like hemorrhoids, fissures, or inflammatory bowel disease may experience more discomfort or complications from the transrectal approach, and a transperineal procedure may be preferable.

Men who have had a prior negative biopsy and are being asked to repeat the procedure based on a persistently elevated PSA should ask about MRI-fusion biopsy rather than accepting another round of systematic sampling. The evidence that targeted biopsy outperforms blind systematic sampling for clinically significant cancer is strong enough that repeating the older approach alone is harder to justify.¹⁵ If your facility does not offer fusion biopsy, it may be worth a referral to one that does.